2 Thermo Fisher Way
171 articles with ViewRay Incorporated
ViewRay, Inc. announced that it has commenced an underwritten public offering of $125.0 million of shares of its common stock.
ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter ended June 30, 2018.
Leading Medical Physics Meeting to Feature More than 50 Presentations on ViewRay's MRIdian MRI-Guided Radiotherapy
Presentations Highlight MRIdian Clinical Experience with On-Table Adaptive Therapy Combined with the Novel Ability to Visualize and Actively Target Tumors that Move
ViewRay Appoints Scott Drake as President, Chief Executive Officer and a Member of the Board of Directors, Shar Matin as Chief Operating Officer, and D. Keith Grossman as a Member of the Board of Directors
New Officers and Directors Bring Extensive Medical Company Growth Experience to ViewRay
UNICANCER to Bring Next Generation Radiotherapy to Centre Georges-François Leclerc (CGFL)
Loyola Medicine/Palos Health Installs ViewRay's MRIdian Linac System for MR Image-Guided Radiation Therapy
Chicago-Area Provider Becomes First Community Hospital in the U.S. with ViewRay's Next Generation Linear Accelerator-Based System
Pioneer of MR Image-Guided Radiotherapy, Washington University, Begins First Clinical Treatments with its Second ViewRay MRIdian System
Next Generation Cancer Therapy Enables Delivery of Higher, Potentially More Effective Radiation Dose Regimens
ViewRay, Inc. announced that James F. Dempsey, PhD, Founder and Chief Scientific Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to present at the Jefferies 2018 Global Healthcare Conference.
ViewRay's Clinical Cooperative Think Tank Convenes to Discuss Clinical Experience and Further Trial Development for MRIdian MR-Image Guided Radiotherapy
ViewRay, Inc. announced today that members of its Clinical Cooperative Think Tank (C2T2) gathered last week in Barcelona, Spain to discuss data from the nearly 3,000 patients treated using ViewRay's MRIdian MR image-guided radiotherapy system.
Miami Cancer Institute at Baptist Health South Florida Becomes Second Institution in the United States to Treat Patients with ViewRay's MRIdian® Linac
ViewRay, Inc. announced that Miami Cancer Institute at Baptist Health South Florida has begun patient treatments using the company's next generation MR image-guided radiation therapy system, MRIdian® Linac.
VU University Medical Center in Amsterdam Delivers First Ever Linear Accelerator-Based On-Table Adaptive MR Image-Guided Radiotherapy Treatment on ViewRay MRIdian® Linac
ViewRay, Inc. (Nasdaq: VRAY) announced today that VU University Medical Center (VUmc) in Amsterdam has begun patient treatments using the Company's next generation system, MRIdian Linac.
ViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided Radiotherapy
ViewRay, Inc. announced new MR imaging technologies under development for its MRIdian® Linac radiotherapy system.
Oncologists at Leading Swiss Hospital Select MRIdian Linac as Preferred Technology In Competitive European Tender
Introduces 2018 revenue guidance of $80-90 million.
Financing to Further Support Growth of MRIdian Linac
The Company also announced the impending resignations of two directors: David Bonita, M.D., and Mark S. Gold, M.D. Both Dr. Bonita and Dr. Gold announced their intention to step down from the Board at the Company's Annual Meeting.
ViewRay today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2017.
Total revenue of $12.2M in Q3 2017, up from $.04M in Q3 2016.
Washington University Completes Installation of Second MRIdian MR-Guided Radiotherapy System From ViewRay
This marks the hospital's second MRIdian system, furthering their leadership role in the delivery of MR-guided radiation therapy.
ViewRay Announces Conference Call and Webcast of Third Quarter 2017 Financial Results to be Held on November 13, 2017
ViewRay will hold a conference call on Monday, November 13, 2017 at 8:30 a.m. ET / 5:30 a.m. PT to discuss the results.